Teza Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,481
Closed -$478K 200
2025
Q2
$478K Sell
5,481
-2,557
-32% -$217K 0.36% 95
2025
Q1
$722K Buy
+8,038
New +$719K 0.33% 89
2024
Q4
Sell
-50,491
Closed -$4.55M 634
2024
Q3
$4.55M Buy
50,491
+7,389
+17% +$622K 0.5% 45
2024
Q2
$3.39M Sell
43,102
-3,392
-7% -$278K 0.42% 57
2024
Q1
$4.05M Buy
46,494
+41,353
+804% +$3.53M 0.54% 47
2023
Q4
$424K Buy
+5,141
New +$392K 0.07% 330
2023
Q3
Sell
-4,253
Closed -$375K 705
2023
Q2
$375K Sell
4,253
-38,387
-90% -$3.3M 0.06% 352
2023
Q1
$3.44M Buy
+42,640
New +$3.48M 0.74% 21
2022
Q3
Sell
-18,699
Closed -$1.68M 589
2022
Q2
$1.68M Buy
+18,699
New +$1.89M 0.64% 18
2022
Q1
Sell
-23,593
Closed -$2.44M 480
2021
Q4
$2.44M Buy
23,593
+7,404
+46% +$857K 0.65% 31
2021
Q3
$2.03M Buy
+16,189
New +$2.1M 0.98% 17
2021
Q2
Sell
-8,676
Closed -$1.02M 642
2021
Q1
$1.02M Buy
+8,676
New +$1.02M 0.2% 147
2020
Q4
Sell
-7,346
Closed -$763K 380
2020
Q3
$763K Sell
7,346
-41,341
-85% -$4.15M 0.45% 51
2020
Q2
$4.46M Buy
+48,687
New +$4.67M 0.99% 8
2020
Q1
Sell
-5,900
Closed -$669K 350
2019
Q4
$669K Buy
+5,900
New +$647K 0.18% 184
2019
Q3
Sell
-2,861
Closed -$279K 568
2019
Q2
$279K Sell
2,861
-16,767
-85% -$1.53M 0.16% 222
2019
Q1
$1.79M Buy
+19,628
New +$1.76M 0.95% 15
2018
Q4
Sell
-2,513
Closed -$247K 421
2018
Q3
$247K Buy
+2,513
New +$232K 0.06% 331
2018
Q2
Sell
-12,652
Closed -$1.01M 534
2018
Q1
$1.01M Buy
12,652
+2,853
+29% +$235K 0.24% 146
2017
Q4
$791K Buy
+9,799
New +$785K 0.48% 86

Other funds holding MDT

Teza Capital Management's MDT Position: Q3 2025 in Review

Teza Capital Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 5,481 shares — an estimated $478K sold.

Teza Capital Management first reported a position in MDT in Q4 2017 and held it in 20 quarters. The position peaked at $4.55M in Q3 2024. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Teza Capital Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 5,481 Medtronic shares in Q3 2025, an estimated $478K.
  • Teza Capital Management first reported a position in Medtronic in Q4 2017 and held it in 20 quarters.
  • Teza Capital Management's Medtronic position peaked at $4.55M in Q3 2024.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.